This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Berglund, H. Articles by Siegel, R. J. Search for Related Content PubMed PubMed Citation Articles by Berglund, H. Articles by Siegel, R. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Coronary Artery Bypass Surgery Hazardous Substances DB NITROGLYCERIN

(Circulation. 1996;94:2871-2876.)
© 1996 American Heart Association, Inc.

Articles

Preserved Vasodilatory Response to Nitroglycerin in Saphenous Vein Bypass Grafts

Hans Berglund, MD, PhD; Huai Luo, MD; Toshihiko Nishioka, MD; Neal L. Eigler, MD; Chong-Jin Kim, MD; Steven W. Tabak, MD; Robert J. Siegel, MD

the Department of Cardiology, Huddinge (Sweden) Hospital (Karolinska Institute) (H.B.), and the Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, Calif.

Correspondence to Robert J. Siegel, MD, Division of Cardiology, Room 5335, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048.

Background Uncertainty exists regarding the effects of nitroglycerin on atherosclerotic segments of coronary arteries, and information on vasoreactivity of saphenous vein bypass grafts is sparse. Intravascular ultrasound enables identification of atherosclerosis in angiographically normal segments and allows continuous determination of alterations in cross-sectional lumen areas.

Methods and Results Patients with documented coronary atherosclerosis were studied. Vessel morphology and lumen area at baseline and after 100 to 200 µg nitroglycerin were assessed at 10-second intervals for 60 seconds in vessel segments without angiographically apparent lesions. Coronary artery saphenous vein bypass grafts from 11 patients were compared with native coronary arteries in 16 different patients. Atherosclerosis was present in all vessel segments studied. There was a rapid increase in lumen area compared with baseline after intravascular nitroglycerin in both native coronary arteries and saphenous vein bypass grafts. Maximum lumen area dilatation was 19.6±12.2% in saphenous vein bypass grafts and 19.7±13.1% in native coronary arteries. An earlier peak response in saphenous vein bypass grafts (34.5±6.9 seconds) compared with native coronary arteries (44.7±8.5 seconds; P=.003) was found. Vessel wall area remained constant during vasodilation, but there was a significant reduction in measured wall thickness (P=.034).

Conclusions In patients with documented coronary artery disease, intravascular ultrasound reveals substantial atherosclerosis in angiographically normal vessel segments. In these vessel segments, both native coronary arteries and saphenous vein bypass grafts exhibit prompt vasodilation with the intravascular administration of nitroglycerin. The vasodilatory capacity in response to nitroglycerin seems to be preserved in transposed, denervated, and devascularized saphenous veins.

Key Words: ultrasonics • coronary disease • grafting • nitroglycerin • atherosclerosis • vasodilation